Skip to content

A pilot study to investigate the effects on fitness and quality of life of an individualised exercise programme for breast cancer patients undergoing radiotherapy.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN26140710
Enrollment
Unknown
Registered
2004-09-30
Start date
2003-11-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer: Breast Cancer Breast

Interventions

The following activities will be in addition to the normal treatment programme, but will be conducted as an extension of out-patient appointments at the hospital during radiotherapy treatment, with 2

Sponsors

Record Provided by the NHSTCT Register - 2004 Update - Department of Health (UK)
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Female participants with breast cancer who are referred for a 3 week course of radiotherapy at the Queen Elizabeth Hospital, University Hospital Birmingham Trust will be invited to participate in the study when they are booked in. Inclusion criteria: 1. Participants will be recruited and randomised to control (n = 5) and intervention (n = 5) groups 2. Be able to complete the modified step test 3. Be able to understand instructions and complete an activity diary 4. Participants between the age of 50-70 years

Exclusion criteria

Exclusion criteria: 1. Participants must be independent in self care and activities of daily living 2. Have no medical condition that prevents their participation in exercise (screening form and clearance for testing completed by Doctors at Clinic appointment) 3. Participants who will not be able to complete the requirements of assessments within the study 4. Participants having chemotherapy In addition to radiotherapy 5. Participants who have participated in the SEACRAB trial 6. Participants who are receiving radiotherapy for more than 3 weeks

Design outcomes

Secondary

MeasureTime frame
Not provided at time of registration

Primary

MeasureTime frame
Not provided at time of registration

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026